P-PLAC 2
Research type
Research Study
Full title
Primary Care - Prescribing Lifestyle Adjustments for Cardiovascular Health (Phase II)
IRAS ID
260480
Contact name
Hannah Parry
Contact email
Sponsor organisation
University of South Wales
Clinicaltrials.gov Identifier
Duration of Study in the UK
0 years, 9 months, 1 days
Research summary
Prescribing lifestyle changes to patients who are at risk of cardiovascular disease, may be an extremely cost effective mechanism of improving health for the individual themselves and the NHS. It is already proved that positive lifestyle changes such as improved diet, increased physical activity, quitting smoking and reducing alcohol consumption can lower the risk of cardiovascular disease, as well as reduce the risk of all-cause mortality. P-PLAC2 (Primary Care – Prescribing Lifestyle Adjustments for Cardiovascular Health) is a Phase II interventional study to determine the efficacy of a Lifestyle Prescription (LRx), from the viewpoint of patients and healthcare professionals. The study uses a mixed methods design, and full study training and support will be provided to staff involved in the recruitment of patients, through to the behaviour change consultation, and end of study. If the study proves successful, a lifestyle prescription (LRx), may be made available to support NHS staff throughout all disciplines (specifically those working with patients who are at risk of CVD), to the engage and provide support to patients, as a preventative measure.
REC name
Wales REC 3
REC reference
19/WA/0129
Date of REC Opinion
4 Jun 2019
REC opinion
Further Information Favourable Opinion